QUADRA: A Phase 2, Open-Label, Single-Arm Study to Evaluate Niraparib in Patients (Pts) with Relapsed Ovarian Cancer (Roc) Who Have Received ≥3 Prior Chemotherapy Regimens.
AuthID
P-00V-TB9
P-00V-TB9